Core Insights - USANA has launched an upgraded version of its Celavive skincare brand, featuring new products and enhanced formulas aimed at achieving youthful and radiant skin [1][3]. Product Innovations - The Celavive Vitalizing Serum now contains over four times the active ingredients, including BioPeptide-CS, Olivol24™, CoQ10, and plant-based Bakuchiol, promoting collagen synthesis and skin radiance [4]. - The Celavive Bi-Phase Makeup Remover is a new lightweight formula that cleanses and conditions the skin, infused with cucumber fruit complex for a soothing effect [5]. - The Celavive Contouring Face & Neck Crème is designed for women aged 35 and above, featuring Feminage™, which supports skin elasticity and smoothness [6]. - The Celavive Triple Action Eye Cream has nearly ten times more active ingredients than its predecessor, targeting fine lines, puffiness, and dark circles [7]. - The Celavive Perfecting Toner has been upgraded to balance pH, boost hydration, and refine skin texture, utilizing a blend of peptides, botanicals, and antioxidants [8]. Brand Ambassadors - USANA has appointed Joy Tan and Violet Chan as global ambassadors for the Celavive brand, leveraging their extensive experience in beauty education to enhance brand engagement [9][10].

Core Insights - USANA has announced advancements to its Nutritionals product line, including enhanced versions of existing products and new offerings aimed at improving global health and wellness practices [1][2][3] New and Upgraded Products - **CellSentials**: Now includes pyrroloquinoline quinone (PQQ) in its InCelligence Complex, supporting mitochondrial biogenesis and cognitive function [3] - **Core Aminos**: A comprehensive essential amino acid formula with HMB, designed for muscle retention and recovery, suitable for athletes and older adults [3] - **Circulate+**: An orange-flavored drink powder that promotes heart health using red spinach extract, vitamin C, and L-Arginine to aid nitric oxide production [3] - **Proflavanol**: Enhanced with a variety of flavonoids for broad antioxidant support, promoting heart health, immune support, and healthy aging [3] - **Marine Collagen Peptides**: A ready-to-drink supplement containing 4.8 grams of marine collagen for skin and joint health, designed for convenience [3] - **BiOmega**: An upcoming omega-3 supplement in triglyceride form for improved bioavailability, containing concentrated EPA and DHA [3] Company Overview - USANA is recognized for its quality nutritional and lifestyle products, with over 30 years of experience and adherence to strict Good Manufacturing Practices in its FDA-registered facility [5]

Core Insights - The U.S. self-improvement industry is valued at $12 billion annually, highlighting its significance in personal and collective growth [1] - Kevin Guest, Executive Chairman of USANA Health Sciences, emphasizes that true success involves living a life of purpose and fulfillment, particularly during Self-Improvement Month [2] - Guest's personal journey illustrates the importance of self-improvement, emphasizing preparation and integrity as key lessons learned from past challenges [3][4] Company Overview - USANA Health Sciences is a global leader in health and wellness products, founded in 1992, and has a strong focus on social wellness as part of its business strategy [6] - The company operates in 25 countries, prioritizing clear communication to build trust with customers and distributors [7] Self-Improvement Initiatives - Guest encourages conducting a "Life Audit" with a trusted friend to gain external perspectives on personal growth areas [4] - Creating a "Reverse Bucket List" is suggested to reflect on past accomplishments, boosting confidence and identifying success patterns [4] - Learning practical "Survival Skills" is recommended as a form of self-improvement that enhances self-reliance and prepares individuals for unexpected situations [4][5]

Company Overview - USANA Health Sciences is a global leader in health and wellness products, founded in 1992, and operates in 25 countries [3] - The company emphasizes the importance of social wellness and clear communication to build trust with customers and distributors [3] Key Insights from Kevin Guest - Kevin Guest, Executive Chairman of USANA, promotes small daily habits for lasting wellness, emphasizing that wellness is a rhythm of life rather than a checklist [1][2] - Guest's book, "All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony," shares personal experiences and insights on overcoming anxiety and building confidence through preparation and small daily acts [2] Daily Habits for Wellness - Seven daily habits are outlined to support long-term well-being: 1. Start with Stillness: Five minutes of quiet can reset the day [4] 2. Fuel with Intention: Proper nutrition is essential for energy and mood [4] 3. Move Every Day: Movement can be simple and does not require a gym [4] 4. Speak Kindly, Especially to Yourself: Positive self-talk is crucial [4] 5. Choose Connection: Strong relationships are vital for wellness [4] 6. Protect Your Yes: Setting boundaries is a form of self-respect [4] 7. End With Gratitude: A daily gratitude practice can promote peace [4] Social Responsibility - Proceeds from Guest's book go towards feeding hungry children, with each purchase providing 40 meals [2]

Core Viewpoint - USANA Health Sciences (USNA) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook based on an upward trend in earnings estimates, which significantly influences stock prices [1][2]. Earnings Estimates and Stock Price Impact - The Zacks rating system is based on changes in earnings estimates, which are strongly correlated with near-term stock price movements. Institutional investors utilize these estimates to determine the fair value of stocks, leading to buying or selling actions that affect stock prices [3][4]. - Rising earnings estimates for USANA Health suggest an improvement in the company's underlying business, which could lead to an increase in stock price as investors respond positively to this trend [4]. Zacks Rank System - The Zacks Rank stock-rating system classifies stocks into five groups based on earnings estimates, with a strong historical performance, particularly Zacks Rank 1 stocks generating an average annual return of +25% since 1988 [6]. - The Zacks rating system maintains a balanced distribution of "buy" and "sell" ratings across its universe of over 4,000 stocks, ensuring that only the top 20% receive a "Strong Buy" or "Buy" rating [8][9]. Earnings Estimate Revisions for USANA Health - For the fiscal year ending December 2025, USANA Health is expected to earn $2.62 per share, which remains unchanged from the previous year. However, the Zacks Consensus Estimate has increased by 0.4% over the past three months, indicating a positive trend in earnings expectations [7].

Core Insights - The article emphasizes the investment philosophy focused on small cap companies, highlighting the importance of identifying mispriced securities through understanding financial drivers and utilizing DCF model valuation [1] Group 1: Investment Philosophy - The investment approach is not confined to traditional categories such as value, dividend, or growth investing, but rather considers all prospects of a stock to assess risk-to-reward [1] Group 2: Market Focus - The investment strategy encompasses markets in the US, Canada, and Europe, indicating a broad geographical focus for potential investment opportunities [1]

Financial Data and Key Metrics Changes - Consolidated net sales grew 11% year over year and adjusted earnings per share increased 36% from the prior year [5] - The company ended the quarter debt-free with $151 million in cash on the balance sheet after repaying its line of credit [5] Business Line Data and Key Metrics Changes - The direct-to-consumer business, HYA, showed strong year-over-year top line growth with improved profitability [10] - RiseBar, acquired in 2022, delivered strong double-digit top line growth driven by solid order activity with key retail partners [11] Market Data and Key Metrics Changes - Sales in China outperformed expectations despite a drop in active customers, attributed partly to tariff activity and increased buy-up from consumers [15][16] - The company is optimistic about the long-term potential of the Chinese market despite economic uncertainties [17] Company Strategy and Development Direction - The company is implementing strategic initiatives to strengthen partnerships with brand partners, accelerate product innovation, and evolve brand messaging [6][8] - A new compensation plan is being introduced to modernize and simplify the direct sales model, aimed at attracting new generations of entrepreneurs [8][22] - The company plans to host more in-person events and launch several new products at the upcoming global convention [9][10] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's growth outlook for fiscal year 2025, believing that successful execution of strategies will deliver sustainable long-term growth [12][13] - The company is closely monitoring economic uncertainties and tariff impacts but has not seen significant negative effects thus far [23][24] Other Important Information - The company is investing significantly in the third quarter for the global convention and new product launches, which may create short-term pressure on operating margins [12] - The integration of acquired businesses is progressing well, with expectations for synergies and operational efficiencies to be realized in the coming quarters [30][33] Q&A Session Summary Question: Insights on sales performance in China - The performance in China was strong despite a drop in active customers, with tariff activity contributing to increased consumer buy-up [15][16] Question: Active customer count decline - The decline in active customer count was partly due to upcoming changes in the compensation program, which created some reservations among brand partners [18] Question: New brand partner compensation details - The new compensation program allows new brand partners to earn income more quickly, addressing challenges in early success [20][22] Question: Impact of tariffs on overall business - The impact of tariffs has been minimal, with proactive measures taken by the operations and procurement team [23][24] Question: Growth comparison for Chaya's second quarter sales - Chaya experienced significant growth compared to the previous year, with expectations for continued growth as new products are launched [28] Question: Integration synergies and operational efficiencies - The integration of Hyatt is progressing, with expectations for operational efficiencies to be realized in the future [30][33] Question: Share buyback strategy - The company will be opportunistic regarding share buybacks, discussing capital allocation at board meetings [35] Question: Outlook for additional acquisition opportunities - The company has an active M&A department looking for opportunities but will need time to build cash for appealing acquisitions [36]

Financial Data and Key Metrics Changes - Consolidated net sales grew 11% year over year and adjusted earnings per share increased 36% from the prior year [5] - The company ended the quarter debt-free with $151 million in cash on the balance sheet after repaying its line of credit [5] Business Line Data and Key Metrics Changes - The direct-to-consumer business, HYA, showed strong year-over-year top line growth with improved profitability [10] - RiseBar, acquired in 2022, delivered strong double-digit top line growth driven by solid order activity with key retail partners [11] Market Data and Key Metrics Changes - Sales in China outperformed expectations despite a drop in active customers, attributed to tariff activity and increased consumer buying [16][17] - The overall active customer count saw a decline, partially due to upcoming changes in the compensation programs [19] Company Strategy and Development Direction - The company is implementing strategic initiatives to strengthen partnerships with brand partners, accelerate product innovation, and evolve brand messaging [6][7] - A new compensation plan is being introduced to modernize and simplify the direct sales model, aimed at attracting new generations of entrepreneurs [8][22] - The company is focused on enhancing its product offerings and expanding its market reach through acquired businesses [12] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the long-term potential of the Chinese market despite current economic uncertainties [18] - The company remains confident in its fiscal 2025 outlook and believes successful execution of strategies will deliver sustainable long-term growth [12] Other Important Information - The company plans to host a global convention to recognize brand partners and provide actionable training [10] - Investments in the third quarter are expected to create short-term pressure on operating margins due to the global convention and new product launches [12] Q&A Session Summary Question: Insights on sales performance in China - Management noted strong performance in China despite tariff activity, with optimism about long-term potential [16][17] Question: Active customer count decline - The decline was partially attributed to upcoming changes in the compensation program, with expectations for recovery in the third quarter [19] Question: New brand partner compensation details - Adjustments were made to allow new brand partners to earn income earlier in their journey, enhancing the incentive program [21][22] Question: Impact of tariffs on business - The impact of tariffs has been minimal, with proactive measures taken by the operations team [23][24] Question: Growth comparison for Chaya - Chaya experienced significant growth compared to the previous year, with expectations for continued growth in the coming months [25][27] Question: Integration synergies and operational efficiencies - Management is optimistic about operational initiatives and synergies from the integration of Hyatt, with progress expected in the coming quarters [28][30] Question: Future acquisition opportunities - The company has an active M&A department looking for opportunities, but it will take time to build sufficient cash for new acquisitions [33] Question: Competitive advantage from health initiatives - The company is well-positioned to respond to health trends, particularly in children's health through the acquisition of Hyatt [40][43] Question: Tools and infrastructure for brand partners - Enhancements to IT infrastructure and tools are being developed to support brand partners in growing their businesses [45][46][48]

Group 1: Earnings Performance - USANA Health Sciences reported quarterly earnings of $0.74 per share, exceeding the Zacks Consensus Estimate of $0.54 per share, and up from $0.54 per share a year ago, representing an earnings surprise of +37.04% [1] - The company posted revenues of $235.85 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 4.73%, compared to year-ago revenues of $212.87 million [2] - Over the last four quarters, USANA has surpassed consensus EPS estimates four times and topped consensus revenue estimates three times [2] Group 2: Stock Performance and Outlook - USANA Health shares have declined approximately 15.6% since the beginning of the year, while the S&P 500 has gained 7.2% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the coming quarter is $0.65 on revenues of $225.82 million, and for the current fiscal year, it is $2.61 on revenues of $946.98 million [7] Group 3: Industry Context - The Medical - Drugs industry, to which USANA belongs, is currently ranked in the top 35% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact USANA's stock performance [5] - Another company in the same industry, Aquestive Therapeutics, is expected to report a quarterly loss of $0.18 per share, reflecting a significant year-over-year decline [9]

[Q2 2025 Financial Highlights](index=1&type=section&id=Key%20Financial%20Results) USANA's Q2 2025 saw consolidated net sales rise 11% to $236 million, with GAAP net earnings declining but adjusted diluted EPS growing 36% Q2 2025 Financial Performance vs. Q2 2024 | Metric | Q2 2025 | YoY Change | Sequential Change | | :--- | :--- | :--- | :--- | | **Net Sales** | $236 million | +11% | -5% | | **Net Earnings** | $9.7 million | -7% | +3% | | **Diluted EPS** | $0.52 | -4% | +6% | | **Adjusted Diluted EPS** | $0.74 | +36% | +1% | | **Adjusted EBITDA** | $30.5 million | +13% | +2% | - Direct selling Active Customers decreased to **418,000** from **468,000** in the prior year, while the newly acquired Hiya business reported **200,400** Active Monthly Subscribers[4](index=4&type=chunk) - Management confirmed that the business performed in line with expectations and maintained the fiscal 2025 outlook[5](index=5&type=chunk) [Management Commentary and Strategy](index=2&type=section&id=Management%20Commentary) Management is implementing a new commercial strategy for direct sales, rebranding members as 'Brand Partners,' while the Hiya DTC business shows strong growth and a new Disney partnership - The company is rolling out a new commercial strategy for its direct sales business, which involves enhanced sales incentives, a simplified model, improved business support, and refreshed brand messaging[6](index=6&type=chunk) - The terminology for members of the direct sales business has been changed to "**Brand Partner**"[6](index=6&type=chunk) - The Hiya business demonstrated strong top-line growth and improved profitability, launching a new partnership with Disney featuring special edition Lion King and Princesses branded multivitamins[7](index=7&type=chunk) [Business Segment & Regional Performance](index=2&type=section&id=Business%20Segment%20%26%20Regional%20Performance) Direct selling sales declined across all regions, totaling $199.1 million, while the Hiya direct-to-consumer segment generated $34 million in net sales [Direct Selling Regional Results](index=2&type=section&id=Direct%20Selling%20Regional%20Results) Q2 2025 Direct Selling Performance by Region (YoY) | Region | Net Sales (Millions) | YoY Change | Active Customers (Thousands) | YoY Change | | :--- | :--- | :--- | :--- | :--- | | **Asia Pacific** | $163 | -4% | 336 | -9% | | Greater China | $113 | -2% | 231 | -8% | | North Asia | $17 | -13% | 37 | -12% | | Southeast Asia Pacific | $33 | -7% | 68 | -12% | | **Americas and Europe** | $39 | -8% | 82 | -17% | [Hiya Direct-to-Consumer Results](index=3&type=section&id=Hiya%20Direct%20to%20Consumer%20Results) Q2 2025 Hiya Performance | Metric | Value | | :--- | :--- | | **Net Sales** | $34 million | | **Active Monthly Subscribers** | 200,400 | [Financial Position and Capital Allocation](index=3&type=section&id=Balance%20Sheet%20and%20Share%20Repurchase%20Activity) USANA maintained a strong balance sheet with $151 million cash and no debt, generating $13 million in operating cash flow and repurchasing $15 million in shares - Generated **$13 million** in operating cash flow during the second quarter[11](index=11&type=chunk) - Ended the quarter with **$151 million** in cash and cash equivalents and **zero debt**[11](index=11&type=chunk) - Repurchased **528,000 shares** for **$15 million**, with approximately **$34 million** remaining under the current share repurchase authorization[11](index=11&type=chunk) [Fiscal Year 2025 Outlook](index=3&type=section&id=Fiscal%20Year%202025%20Outlook) USANA reiterated its FY2025 outlook, projecting consolidated net sales of $920 million to $1.0 billion, driven by Hiya growth despite direct sales promotional costs Fiscal Year 2025 Guidance | Metric | Range | | :--- | :--- | | **Consolidated Net Sales** | $920 million to $1.0 billion | | **Net Earnings** | $29 million to $41 million | | **Diluted EPS** | $1.50 to $2.20 | | **Adjusted Diluted EPS** | $2.35 to $3.00 | | **Adjusted EBITDA** | $107 million to $123 million | - The outlook anticipates net sales from the direct selling business of **$775 million to $840 million**[15](index=15&type=chunk) - Net sales from Hiya are projected to be **$145 million to $160 million**, reflecting significant year-over-year growth of **29% to 42%**[15](index=15&type=chunk) - The outlook includes an effective tax rate of **44.0% to 45.0%** and accounts for fiscal 2025 being a 53-week year[15](index=15&type=chunk) [Non-GAAP Financial Measures & Reconciliations](index=5&type=section&id=Non-GAAP%20Financial%20Measures) USANA provides non-GAAP measures like Adjusted EBITDA and Adjusted Diluted EPS, excluding acquisition-related costs, to offer a clearer view of core operational performance - **Adjusted Diluted EPS** is a non-GAAP measure that excludes acquisition-related costs like transaction costs, integration expenses, and amortization of intangible assets[16](index=16&type=chunk)[20](index=20&type=chunk) - **Adjusted EBITDA** is a non-GAAP measure that adjusts net earnings for interest, taxes, depreciation, amortization, non-cash share-based compensation, and transaction/integration costs for the Hiya acquisition[17](index=17&type=chunk)[19](index=19&type=chunk) Q2 2025 GAAP to Non-GAAP Reconciliation Highlights | Metric | GAAP | Adjustments | Non-GAAP (Adjusted) | | :--- | :--- | :--- | :--- | | **Net Earnings (attributable to USANA)** | $9.7 million | +$4.1 million | $13.7 million | | **Diluted EPS** | $0.52 | +$0.22 | $0.74 | [Financial Statements](index=12&type=section&id=Financial%20Statements) The condensed consolidated financial statements detail performance, showing gross profit at $185.7 million, earnings from operations at $16.7 million, total assets at $734.5 million, and total liabilities at $148.9 million Condensed Consolidated Statement of Operations (Q2 2025 vs Q2 2024, in thousands) | Line Item | Q2 2025 | Q2 2024 | | :--- | :--- | :--- | | **Net sales** | $235,848 | $212,869 | | **Gross profit** | $185,664 | $172,536 | | **Earnings from operations** | $16,718 | $17,840 | | **Net earnings attributable to USANA** | $9,655 | $10,432 | Condensed Consolidated Balance Sheet (As of June 28, 2025, in thousands) | Line Item | Amount | | :--- | :--- | | **Cash and cash equivalents** | $151,338 | | **Total current assets** | $261,866 | | **Total assets** | $734,526 | | **Total current liabilities** | $121,625 | | **Total stockholders' equity** | $531,060 | - Total Active Brand Partners decreased from **193,000** in Q2 2024 to **172,000** in Q2 2025, while Total Active Preferred Customers decreased from **275,000** to **246,000** over the same period[37](index=37&type=chunk)[38](index=38&type=chunk)